2020 Virtual PGC Series

oao_logo_color OMA-LogoName_large

Joint Providership provided by the Oregon Medical Association.


Virtual Meeting:

Due to Oregon’s reopening guidelines and restrictions, we are prohibited from convening large gatherings likely well into this winter. Accordingly, the Oregon Academy of Ophthalmology Board of Directors has made the decision to prioritize your safety while continuing to provide a high-quality CME event – by going virtual!

Since you have already registered for the 2020 Post Graduate Convention, you have already secured access to the 2020 Virtual PGC Series! We have lined up the same renowned faculty and course offerings and we have added two guest speakers with new topics. Courses will be posted online as they become available and will all be accessible on demand from the comfort of your home/office at a day and time that best fits your schedule! You can begin viewing the courses on July 15, 2020 and all content will be available through December 31, 2020. 


Date

July 15, 2020 – December 31, 2020


Registration

Your registration for the previously scheduled March 13-14, 2020 Post Graduate Convention has been transferred to the OAO 2020 Virtual PGC Series and no further action is needed on your part.

Not Registered? Click here to register for the OAO 2020 Virtual PGC Series.


Frequently Asked Questions

Click here to see a list of frequently asked questions regarding the OAO 2020 Virtual PGC Series. This list will be updated as new questions are received.


Materials


Target Audience

This activity has been planned for ophthalmology physicians (practicing and retired), and residents in the Pacific Northwest.


Accreditation | CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Providership of the Oregon Medical Association (OMA) and the Oregon Academy of Ophthalmology (OAO). The OMA is accredited by the ACCME to provide continuing medical education for physicians.

The Oregon Medical Association has designated this virtual activity for a maximum of 13 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


2020 Faculty & Lectures

CORNEA | Penny Asbell, MD

Barrett G. Haik Chair for Ophthalmology, University of Tennessee, Hamilton Eye Institute, Memphis, TN

  • Cross-linking for Keratoconus & Corneal Infections
  • Herpes Zoster & the ZEDS Study
  • Making the DREAM Come True!
  • Workshop: Challenging Cornea Cases

PEDIATRICS/STRABISMUS | Alejandra de Alba Campomanes, MD

Professor of Clinical Ophthalmology, UCSF Benioff Children’s Hospital, San Francisco, CA

  • Botulinum Toxin Use for Strabismus
  • Management of Adult Strabismus Secondary to Ocular Surgery

GLAUCOMA | Jonathan S. Myers, MD

Chief, Glaucoma Service, Wills Eye Hospital and Associate Professor of Ophthalmology, Thomas Jefferson University’s Sidney Kimmel Medical College, Philadelphia, PA

  • Journal Club: What’s Happened Since OHTS?
  • MIGS: Which Surgery for Which Patient for Which Surgeon?
  • Glaucoma: New Algorithms & Depot Meds
  • Workshop: Coma Conundrums

OCULOPLASTICS | Daniel Rootman, MD

Doheny Eye Center UCLA, Pasadena, CA

  • Multidisciplinary Management of Orbital Vascular Malformations
  • Patient Heterogeneity & Multimodality Management in Thyroid Eye Disease
  • Ptosis Physiology & Mechanisms of Repair
  • Workshop: Orbital Cases – Fracture, Lacrimal Mass, Vascular, Apex Mass

Mitchell Brinks, MD

Assistant Professor of Ophthalmology, School of Medicine, Oregon Health & Science University, Casey Eye Institute, Portland, OR

CHAIR, VISION 2020 USA

  • Vision 2020 USA: A powerful instrument for ophthalmologists to better eye health in Oregon

Donald E. Girard, MD, MACP

Emeritus Professor of Medicine, Division of General Internal Medicine, School of Medicine, Oregon Health & Science University, Portland, OR

PHYSICIAN WELLNESS

  • The Oregon Wellness Program: An Aid to Enhanced and Renewed Professional Satisfaction

Dan Briceland, MD and Linda Harrison, PhD

The Ophthalmic Mutual Insurance Company, San Francisco, CA

PHYSICIAN LIABILITY

  • COVID-19 Challenges: How to Mitigate Risk


Course Descriptions & Objectives

Making the DREAM Come True! | Penny Asbell, MD
This course will use the recently completed DREAM trial and the publication in the NEJM to teach best practices for randomized clinical trials and their interpretation.

  1. Learn the key steps in planning a clinical trial
  2. Define key question(s) to be answered
  3. Understand inclusion/exclusion criteria
  4. Understand outcome measures and the use of biomarkers

Cross-linking for Keratoconus and for Corneal Infections | Penny Asbell, MD
Describe on CXL works and how it may impact corneal infections and the clinical trial to determine its safety and efficacy for corneal infections.

  1. Learn the importance of improving treatment of corneal infections
  2. Learn how CXL might impact treatment
  3. Understand the key parts of the RCT for CXL use in eye infections

Herpes Zoster & the ZEDS Study | Penny Asbell, MD
This course will review the epidemiology of shingles, how to treat and the role of ZEDS to increase understanding of shingles and the eye and how to treat and the role of vaccines in this disease.

  1. Understand typical presentation of HZO
  2. Understand epidemiology of HZO
  3. Learn current treatments of HZO
  4. ZEDS trial – inclusion, exclusion criteria
  5. Use of vaccines

Multidisciplinary Management of Orbital Vascular Malformations | Daniel Rootman, MD
In this course we will review the classification, diagnosis and multimodal management of vascular malformations of the orbit.

  1. Understand the classification of vascular malformations
  2. Apply appropriate diagnostics for vascular malformations in the orbit
  3. Appropriately select management strategy based on the characteristics of the vascular malformation

Patient Heterogeneity & Multimodality Management in Thyroid Eye Disease | Daniel Rootman, MD
In this course we will review the layers of overlapping complexity in the heterogeneous presentation of TED and the range of global and specific therapeutic options available to patients.

  1. Understand the layers of complexity in heterogeneous presentation
  2. Expand the toolbox of available therapeutic options
  3. Apply options to appropriate clinical situations

Ptosis Physiology & Mechanisms of Repair | Daniel Rootman, MD
In this course we will discuss the limitations of a mechanical theory for ptosis and present an alternative systems based approach to understanding the condition.

  1. Understand the limits of a mechanical theory of ptosis
  2. Understand alternate theories of ptosis
  3. Consider these alternate theories in surgical selection and management of patient expectations

Botulinum Toxin Use in Strabismus | Alejandra de Alba Campomanes, MD
Review and discussion of evidence-based  indications and outcomes of the treatment of strabismus with Botulinum toxin.

  1. Understand which strabismus patients will benefit most from this intervention
  2. List the advantages and disadvantages of Botulinum toxin compared to surgery for the treatment of specific forms of strabismus
  3. Better identify subsets of patients with the highest potential for therapeutic success

Management of Adult Strabismus Secondary to Ocular Surgery | Alejandra de Alba Campomanes, MD
Using a case-based format, algorithms will be discussed for the pre-operative evaluation and post-operative management of some common causes of strabismus and diplopia after ocular surgery.

  1. Better evaluate and counsel patients about the risk of postoperative diplopia after ocular surgery, including post-cataract, retinal detachment, pterygium, and glaucoma surgery
  2. Form an algorithm for the evaluation of strabismus after ocular surgery
  3. Gain a more thorough understanding of the risk of postoperative diplopia and possible therapeutic approaches to manage it

Journal Club: What’s Happened Since OHTS? (the more recent major trials in glaucoma) | Jonathan Myers, MD
This lecture will review findings of several major trials, including the EAGLE Trial and ZAP trial, the UKGTS, the LIGHT study, and other studies on MIGS and pharmacological interventions.

  1. Describe the findings of these trials
  2. Discuss the potential for change in treatment paradigm
  3. Apply these to typical glaucoma patient scenarios

Glaucoma: New Algorithms and Depot Meds | Jonathan Myers, MD
This lecture will review three glaucoma medication depot systems in phase III trials. one of these may be approved for use early in 2020, and we will discuss patient selection, risks and benefits, and implications for workflow.

  1. Describe three new depot drug systems for glaucoma
  2. Describe risks and benefits of these new treatments
  3. Analyze which patients are better and worse candidates for these when they are FDA approved

MIGS: Which Surgery for Which Patient for Which Surgeon? | Jonathan Myers, MD
The spectrum of MIGS procedures will be discussed with emphasis on ideal patient selection for each procedure, and which procedures may be most readily adopted based on surgeon experience, interest, and practice patterns.

  1. Describe ideal patients for each MIGS procedure
  2. Discuss risks of each procedure, and which patients may be at greater risks for complications
  3. Choose MIGS procedures to add to their practice based on interest, experience, and practice patterns

Vision 2020 USA: A powerful instrument for ophthalmologists to better eye health in Oregon | Mitchell Brinks, MD
The state, federal, and international eye care systems welcome thoughtful guidance and leadership from ophthalmologists in our community. Beyond specific CMS and coding details there are large scale and important discussions on the science, policies, and politics and how these factors affect our patients and our practices. In this session, we’ll highlight leading edge of debate for several important questions in this arena that affect your day to day practice.

  1. Articulate the newest federal government opinions on vision and eye health.
  2. Assess the strengths and weaknesses in local and federal vision and eye health legislative priorities
  3. Identify the key national participants in the debate on how to improve eye health in the U.S.

The Oregon Wellness Program: An Aid to Renewed & Enhanced Professional Satisfaction | Donald E. Girard, MD, MACP
This course will educate ophthalmologists about the Oregon Wellness Program, how to access the program and how it can help ophthalmologists and their practices.

  1. Learn about the Oregon Wellness Program and how to access the program.
  2. Understand why professional burnout is a destructive force for healthcare professionals, how it is diagnosed and how it can be successfully managed.
  3. Answer your questions about the current state of professional satisfaction.

COVID-19 Challenges: How to Mitigate Risk | Dan Briceland, MD & Linda Harrison, PhD
COVID-19 has presented new challenges to physicians in all aspects of delivering care. This course will describe the risks associated with deferred care, resuming office visits and surgery, and telemedicine care. Risk mitigation strategies will be offered for each category. Expectations regarding the types of medical professional liability claims related to COVID-19 will be discussed.

  • Identify these risks in the COVID-19 environment:
    • Deferring care, clinical care, care via telemedicine, resuming surgery
  • Mitigate those risks via:
    • Systems, protocols and trusted sources, documentation and communication, staff training
  • Anticipate types of COVID-19 related claims